Next article Search Articles Instructions for authors  Access Statistics | Citation Manager  
CASE REPORT  

 Article Access Statistics
    Viewed372    
    Printed8    
    Emailed0    
    PDF Downloaded83    
    Comments [Add]    

Recommend this journal

Heterotopic caval valve implantation in severe tricuspid regurgitation


1 Cardiac Anesthesia and Critical Care, Medanta-The Medicity, Gurugram, Haryana, India
2 Interventional Cardiology, Medanta-The Medicity, Gurugram, Haryana, India
3 Clinical and Preventive Cardiology, Medanta-The Medicity, Gurugram, Haryana, India

Correspondence Address:
Neeraj Kumar Sharma
Senior Consultant, Cardiac Anesthesia and Critical Care, Medanta-The Medicity, Sector-38, Gurugram -122 001, Haryana
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/aca.ACA_72_20

Rights and Permissions

Year : 2021  |  Volume : 24  |  Issue : 3  |  Page : 365-368

 

SEARCH
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles

  Article in PDF (1,220 KB)
Email article
Print Article
Add to My List
Severe symptomatic tricuspid regurgitation (TR) with right heart failure is associated with significant morbidity and mortality. Medical therapy is often ineffective and surgical correction is not feasible due to prohibitive perioperative risk. Transcatheter caval valve implantation (CAVI) is an evolving therapeutic option for this condition. It refers to the heterotopic placement of a valve into the inferior vena cava alone or with a second valve in the superior vena cava to restrict the backflow from the failing tricuspid valve. We hereby describe a patient with previous mitral valve surgery with chronic severe TR who underwent successful CAVI at our institute.






[FULL TEXT] [PDF]*
 

 

 

 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 
 
 Reader Comments
 Email Alert *
  *
 * Requires registration (Free)
 
 CASE REPORT
 




1 Cardiac Anesthesia and Critical Care, Medanta-The Medicity, Gurugram, Haryana, India
2 Interventional Cardiology, Medanta-The Medicity, Gurugram, Haryana, India
3 Clinical and Preventive Cardiology, Medanta-The Medicity, Gurugram, Haryana, India

Correspondence Address:
Neeraj Kumar Sharma
Senior Consultant, Cardiac Anesthesia and Critical Care, Medanta-The Medicity, Sector-38, Gurugram -122 001, Haryana
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/aca.ACA_72_20

Rights and Permissions

Severe symptomatic tricuspid regurgitation (TR) with right heart failure is associated with significant morbidity and mortality. Medical therapy is often ineffective and surgical correction is not feasible due to prohibitive perioperative risk. Transcatheter caval valve implantation (CAVI) is an evolving therapeutic option for this condition. It refers to the heterotopic placement of a valve into the inferior vena cava alone or with a second valve in the superior vena cava to restrict the backflow from the failing tricuspid valve. We hereby describe a patient with previous mitral valve surgery with chronic severe TR who underwent successful CAVI at our institute.






[FULL TEXT] [PDF]*


        
Print this article     Email this article